Macquarie Group
OXFD

Macquarie Group’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Macquarie Group’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-7,881
Closed -$108K – 1952
2019
Q2 		$108K Buy
+7,881
New +$121K ﹤0.01% 1683

Other funds holding OXFD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Macquarie Group's OXFD Position: Q3 2019 in Review

Macquarie Group sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q3 2019, closing a stake of 7,881 shares — an estimated $108K sold.

Macquarie Group first reported a position in OXFD in Q2 2019 and held it in 1 quarter. The position peaked at $108K in Q2 2019. 73 funds tracked by Wall St. Rank hold OXFD as of Q3 2019.

  • Macquarie Group reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q3 2019 after selling out during the quarter.
  • Macquarie Group sold 7,881 Oxford Immunotec Global PLC Ordinary Shares shares in Q3 2019, an estimated $108K.
  • Macquarie Group first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q2 2019 and held it in 1 quarter.
  • Macquarie Group's Oxford Immunotec Global PLC Ordinary Shares position peaked at $108K in Q2 2019.
  • 73 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q3 2019.

Based on Macquarie Group's 13F filing for Q3 2019, filed 14 Nov 2019.